Komori
Earnings presentation3762TECHMATRIX CORPORATIONInformation and Communications, Services and Others

FY2027 (43rd fiscal year) Second-Quarter Earnings Supplementary Materials

In the first half of FY2027, revenue, operating profit, profit before tax and interim profit attributable to owners of the parent exceeded the same period of the previous year, each reaching a record high for a cumulative second quarter. The full-year forecasts remain unchanged from the initial plan. First-half revenue was broadly in line with plan, while operating profit and below exceeded plan.

Worth reading
67In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
5621
¥ millions (year-on-year change in revenue)
Wording
Conditional
How definitive the wording is.

Contents of this document

Supplementary materials to the earnings reportSecond quarter of the fiscal year ending March 202713 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥38,999 million+16.8%
Operating profit¥3,507 million+10.5%
Ordinary income¥3,569 million +11.5%IFRS profit before tax
Net income¥2,373 million +12.7%interim profit attributable to owners of the parent
Operating profit margin
Rate9
Year-on-year change (points)-0.5
Full-year earnings forecast
Revenue
¥81,800 million
Operating profit
¥8,200 million
Pretax profit
¥8,280 million
Profit for the period attributable to owners of the parent
¥5,380 million
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
Both revenue and operating profit came in at forecast levels
Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
  • Higher revenue in the Information Infrastructure Business¥4,642 million
  • Higher revenue in the Applications & Services Business¥742 million
  • Higher revenue in the Medical Systems Business¥236 million
  • Higher operating profit in the Information Infrastructure Business¥294 million
  • Improved operating profit in the Applications & Services Business¥260 million
  • Lower operating profit in the Medical Systems Business¥-221 million
  • Higher consolidated revenue¥5,621 million
  • Higher consolidated operating profit¥333 million
New initiatives
  • Cross-selling of AI-powered SOC automation solutions
  • Expansion of the AI-powered medical image diagnosis support platform
  • Commercialization of generative AI technology, including FastGenie
  • Policy of executing a ¥3.2 billion share buyback and aiming for a total payout ratio of 100%
Key KPIsA metric the company considers important as a management benchmark.
  • Orders received¥53,745 million
    Year on year against the same period last year+23.1%
  • Order backlog¥120,262 million
    Year on year against the same period last year+22.2%
  • Recurring revenue ratio (standalone + PSP)83.5 %
  • Consecutive periods of revenue growth24 consecutive periods
  • Number of patients with images stored on NOBORI7,611 10,000 people
  • Number of examinations stored on NOBORI5.2 100 million examinations
Segment results
Information Infrastructure
Revenue
¥28,872 million+19.2%
Operating profit
¥3,220 million+10.0%
App. Sa.
Revenue
¥5,458 million+15.7%
Operating profit
¥206 million
Healthcare systems
Revenue
¥4,668 million+5.3%
Operating profit
¥80 million-73.3%
Medium-term management plan targets
Period CoveredFY2024–FY2026
Growth Investment¥10–15 billion
M&A and other activities¥10–15 billion
Dividend¥5–7 billion
Working Capital¥25.0-30.0 billion
Comparison with actual resultsInvested approximately ¥17.5 billion over the two years of the FY2024-FY2026 medium-term plan
Financial targets
ROE
Results20.5 %
Cost of capital
Assumption7 Approximately %
Market Size / Share
Market Size
42 Trillion yen stated as the amount of market capitalization lost in the software market
Orders received and order backlog
Orders received
¥53,745 million
Order backlog
¥120,262 million
Number of employees
Consolidated total1,916 people
Change during the period+94 people year on year
Annual Dividend
56 Yen per share
Interim¥24 (actual)
End of period¥32 (forecast)
Payout ratio
40 % policy guideline
Total payout ratioAiming for 100%
DOE7% guideline
Acquisition of treasury shares
32 Hundreds of millions of yen
PeriodFY2026 (fiscal year ending March 2027)
Contents of this document
ItemDetails
Document typeSupplementary materials to the earnings report
Fiscal Period CoveredSecond quarter of the fiscal year ending March 2027
Net Sales¥38,999 million (YoY +16.8%)
Operating profit¥3,507 million (YoY +10.5%)
Ordinary income¥3,569 million (IFRS profit before tax) (YoY +11.5%)
Net income¥2,373 million (interim profit attributable to owners of the parent) (YoY +12.7%)
Operating profit marginRate 9 / Year-on-year change (points) -0.5
Full-year earnings forecastRevenue ¥81,800 million / Operating profit ¥8,200 million / Pretax profit ¥8,280 million / Profit for the period attributable to owners of the parent ¥5,380 million
Self-assessment against the planBoth revenue and operating profit came in at forecast levels
Segment resultsInformation Infrastructure Revenue ¥28,872 million (YoY +19.2%) / Operating profit ¥3,220 million (YoY +10.0%) / App. Sa. Revenue ¥5,458 million (YoY +15.7%) / Operating profit ¥206 million / Healthcare systems Revenue ¥4,668 million (YoY +5.3%) / Operating profit ¥80 million (YoY -73.3%)
Breakdown of Factors Affecting the ChangeFactors Higher revenue in the Information Infrastructure Business / Amount ¥4,642 million, Factors Higher revenue in the Applications & Services Business / Amount ¥742 million, Factors Higher revenue in the Medical Systems Business / Amount ¥236 million, Factors Higher operating profit in the Information Infrastructure Business / Amount ¥294 million, Factors Improved operating profit in the Applications & Services Business / Amount ¥260 million, Factors Lower operating profit in the Medical Systems Business / Amount ¥-221 million, Factors Higher consolidated revenue / Amount ¥5,621 million, Factors Higher consolidated operating profit / Amount ¥333 million
Key KPIsIndicator name Orders received / Value ¥53,745 million / Year on year against the same period last year ¥23.1 million, Indicator name Order backlog / Value ¥120,262 million / Year on year against the same period last year ¥22.2 million, Indicator name Recurring revenue ratio (standalone + PSP) / Value 83.5 % / Year on year against the same period last year Not disclosed, Indicator name Consecutive periods of revenue growth / Value 24 consecutive periods / Year on year against the same period last year Not disclosed, Indicator name Number of patients with images stored on NOBORI / Value 7,611 10,000 people / Year on year against the same period last year Not disclosed, Indicator name Number of examinations stored on NOBORI / Value 5.2 100 million examinations / Year on year against the same period last year Not disclosed
Number of employeesConsolidated total 1,916 people / Change during the period +94 people year on year
Medium-term management plan targetsPeriod Covered FY2024–FY2026 / Growth Investment ¥10–15 billion / M&A and other activities ¥10–15 billion / Dividend ¥5–7 billion / Working Capital ¥25.0-30.0 billion / Comparison with actual results Invested approximately ¥17.5 billion over the two years of the FY2024-FY2026 medium-term plan
Financial targetsROE Results 20.5 % / Cost of capital Assumption 7 Approximately %
Annual Dividend56 Yen per share
Payout ratio40 % (policy guideline)
Acquisition of treasury sharesAmount 32 Hundreds of millions of yen / Period FY2026 (fiscal year ending March 2027)
Orders received and order backlogOrders received ¥53,745 million / Order backlog ¥120,262 million
Market Size / ShareMarket Size 42 Trillion yen (stated as the amount of market capitalization lost in the software market) / Share Not disclosed
New initiativesCross-selling of AI-powered SOC automation solutions, Expansion of the AI-powered medical image diagnosis support platform, Commercialization of generative AI technology, including FastGenie, Policy of executing a ¥3.2 billion share buyback and aiming for a total payout ratio of 100%
Items this document does not state (10)
Gross Profit MarginSelling, general and administrative expensesResults for the three months of the current quarterProgress against full-year forecastUnit price and quantity metricsNumber of stores and locationsAssumptions Underlying the Business OutlookRisk amount incorporated into the outlookCapital expendituresKey points of the Q&A

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

In the Information Infrastructure Business, cross-selling of AI-powered SOC automation solutions alongside cloud-based security products, as well as the accumulation of multi-year subscription contracts, contributed to results. In the Applications & Services Business, CRM demand, recurring projects and academic and public-sector solutions performed well, while operating profit improved as the increase in selling, general and administrative expenses was contained. In the Medical Systems Business, operating profit declined due to the period loss at メドメイン and higher personnel and investment costs.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
FY2027 (43rd fiscal year) Second-Quarter Earnings Supplementary Materials | TECHMATRIX CORPORATION (3762) timely disclosure | Komori